Analyst Ratings for Amicus Therapeutics (FOLD)

FOLD Rating Summary

FOLD Price Target Summary

* Over Last 12-Mos
  |   Expand Research on FOLD
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $15.14 (+4.5%) * Over Last 12-Mos
Rating Score: 5.5 / 10   Percentile Rank: 58%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/22/2026 Jefferies Dennis Ding Downgrade Hold
(Buy)
14.50
(16.00)
14.31
(14.49)
1.26% Details
1/5/2026 Guggenheim Whitney Ljem Downgrade Neutral
(Buy)
N/A
(N/A)
14.27
(14.49)
1.54% Details